Related Experiment Video
Updated: Jul 16, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen
1Department of Microbiological Engineering, Jinju National University, Jinju, Gyeongsangnam-Do, 660-758 Korea. g-min@jinju.ac.kr
Abstract:
Recent studies demonstrated that constitutive androstane receptor (CAR) inhibits ER-mediated transactivation of both endogenous and synthetic estrogen responsive promotor in Hep G2. Whereas steroid and xenobiotic receptor (SXR) but not peroxisome proliferator-activated receptor-gamma (PPAR-gamma) was also reported to repress estrogen receptor (ER) transactivation of the synthetic 4ERE in Hep G2, the effects of these xenobiotic nuclear receptors (XNRs) on the endogenous estrogen responsive promotor remain to be determined. Effects of CAR, SXR, and PPAR-gamma on ER transactivation were also examined in three different kinds of breast cancer cell lines. However, except in MCF-7, studies were limited either in single dose response (MDA-MB-231) or with CAR only (MCF-7-K3). And there is presently no report on the effects of CAR, SXR, and PPAR-gamma on ER-mediated transactivation in ovarian-derived CHO-S cells. Accordingly, this article further examined the effects of the endogenous vitellogenin B1 estrogen responsive promotor on the SXR- and PPAR-gamma-modulated ER transactivation in Hep G2, and either dose-dependent or single dose effects of SXR, PPAR-gamma, and CAR in two different breast cancer cell lines and the ovarian-derived cell line respectively, on the ER-mediated transactivation of the synthetic (4ERE)-tk-luciferase reporter. Consistent with the previous report, CAR significantly repressed ER-mediated transactivation of the endogenous vitellogenin B1 promotor in Hep G2 cells. However, contrary to the effects on the synthetic promotor, PPAR-gamma potentiated whereas SXR did not have any effects on the ER transactivation of the vitellogenin promotor in Hep G2. In the breast cancer cell line of MDA-MB-231 in which endogenous ER is known not to be expressed, CAR modestly stimulated ER transactivation of the synthetic 4ERE in a low dose whereas both SXR and PPAR-gamma did not have any effects in all doses examined (20-500 ng). And in both CHO-S and estrogen-independent breast cancer cell line, MCF-7-K3, none of the three xenobiotic receptors significantly influenced the ER-mediated 4ERE transactivation in all doses examined. XNRs modulate ER-mediated transactivation depending on the estrogen response elements (EREs) and estrogen target cell types.
Insights
Constitutive androstane receptor (CAR), steroid and xenobiotic receptor (SXR), and peroxisome proliferator-activated receptor-gamma (PPAR-gamma) differentially modulate estrogen receptor (ER) activity. Their effects vary based on the specific estrogen response element and cell type, impacting ER-mediated transactivation.
Area of Science:
- Endocrinology
- Molecular Biology
- Pharmacology
Background:
- Constitutive androstane receptor (CAR) inhibits ER-mediated transactivation in Hep G2 cells.
- Steroid and xenobiotic receptor (SXR) represses synthetic estrogen receptor (ER) transactivation, but its effect on endogenous promoters is unclear.
- Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) effects on ER transactivation are not fully understood, especially on endogenous promoters.
Purpose of the Study:
- To investigate the effects of CAR, SXR, and PPAR-gamma on ER-mediated transactivation of endogenous and synthetic promoters in various cell lines.
- To determine the influence of these xenobiotic nuclear receptors (XNRs) on ER transactivation in Hep G2, breast cancer, and ovarian cell lines.
- To elucidate how XNRs modulate ER activity based on specific estrogen response elements (EREs) and cellular context.
Main Methods:
- Examined ER transactivation of the endogenous vitellogenin B1 promoter and synthetic 4ERE reporter in Hep G2 cells.
- Assessed dose-dependent and single-dose effects of CAR, SXR, and PPAR-gamma on ER-mediated transactivation in MDA-MB-231, MCF-7-K3, and CHO-S cells.
- Utilized luciferase reporter assays to quantify ER transactivation modulated by XNRs.
Main Results:
- CAR repressed ER transactivation of the vitellogenin B1 promoter in Hep G2 cells, consistent with previous findings on synthetic promoters.
- PPAR-gamma potentiated ER transactivation of the vitellogenin B1 promoter, while SXR had no effect in Hep G2 cells.
- In MDA-MB-231 cells, CAR modestly stimulated ER transactivation at low doses, with no significant effects observed for SXR and PPAR-gamma across all doses. No significant modulation was observed in CHO-S and MCF-7-K3 cells.
Conclusions:
- Xenobiotic nuclear receptors (XNRs) exhibit cell-type and promoter-specific modulation of estrogen receptor (ER) activity.
- The interaction between XNRs and ER is dependent on the nature of the estrogen response element (ERE) and the cellular environment.
- Findings highlight the complex interplay of nuclear receptors in regulating estrogen signaling, with implications for understanding endocrine disruption and drug development.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Signal Transduction: Overview
Typically, signal transduction involves three...
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
Intracellular Hormone Receptors

